Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

ST19_CRUSHI_INJURY_TRAUMAT_AMPUT_PART_ABDOMEN_LOWER_BACK_PELVIS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S38 Cause of death: ICD-10 — S38 2 out of 7 registries used, show all original rules.	46
4. Check minimum number of events None	46
5. Include endpoints None	46
6. Filter based on genotype QC (FinnGen only)	46

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ABDOMEN_LOWER_BACK_LUMBAR_SPINE_PELVIS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S3
Name in latin: Conquassatio et/sive amputatio traumatica abdominis, partis inferioris dorsi et/sive pelvis

NAME	ST19_CRUSHI_INJURY_TRAUMAT_AMPUT_PART_ABDOMEN_LOWER_BACK_PELVIS
CONTROL_EXCLUDE	ST19_INJURI_ABDOMEN_LOWER_BACK_LUMBAR_SPINE_PELVIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S38
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S38
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	46	17	29
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	32.53	14.06	43.35

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(42529406) Shigella sp [Presence] in Stool by Culture

7.83

2.61

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

7.83

2.61

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

7.83

2.61

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

4.17

2.50

1.1

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.53

1.87

1.8

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

117

2.26

1.85

2.1

2.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

163

2.17

1.75

3.6

4.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

241

2.31

1.73

3.8

3.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

138

2.14

1.68

2.5

10.7

1.2

mmol/l

0.64

121

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

130

2.13

1.66

2.4

10.9

1.2

mmol/l

0.95

121

(3018418) pH of Serum or Plasma

2.26

1.64

2.1

3.8

—

7.4

—

(3025941) Bacteria identified in Stool by Culture

3.29

1.64

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.77

1.59

2.3

1.6

—

(3031040) Bacteria [#/volume] in Urine by Automated count

217

2.10

1.53

3.8

—

44.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.98

1.49

1.2

2.7

—

(36660697) Celiac disease serology panel - Serum

2.66

1.46

1.1

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.14

1.40

1.6

2.4

—

(3011288) Drugs identified in Urine by Screen method

3.17

1.39

1.4

1.9

—

(3002256) Pathology report gross observation

2.63

1.37

1.1

1.3

—

(3027008) Opiates [Presence] in Urine

2.72

1.35

1.2

1.5

—

(3028300) Cannabinoids [Presence] in Urine

2.72

1.35

1.2

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

2.72

1.35

1.2

1.5

—

(3027944) Amphetamines [Presence] in Urine

2.72

1.35

1.2

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.68

1.18

1.2

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2.18

1.12

2.6

1.8

—

(3016879) Cocaine [Presence] in Urine

2.54

1.12

1.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2.13

1.11

1.0

1.5

—

(3019225) pH of Specimen

2.42

1.06

1.6

4.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1.98

1.01

2.2

1.5

1.3

1.8

1.24

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2.00

0.97

2.6

1.9

—

(36304419) Bacteria [Presence] in Urine

1.80

0.92

2.9

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1.79

0.86

1.3

4.2

2.3

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1.79

0.86

1.0

1.3

2.3

2.2

g/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.00

0.85

12.0

10.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.75

0.85

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.76

0.83

2.7

3.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.94

0.82

4.5

3.8

34.0

31.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.82

0.0

1.0

—

(3008898) HLA-B27 [Presence]

0.00

0.80

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2.31

0.79

1.2

1.4

—

(40758558) Short blood count panel - Blood

1.70

0.78

4.6

6.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.99

0.78

2.1

1.9

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.73

0.75

1.8

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.74

0.70

1.7

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.74

0.70

1.3

1.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

106

1.62

0.69

2.7

1.9

62.8

87.4

pmol/l

—

(40761535) Cells panel - Urine sediment

1.88

0.68

1.6

3.9

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.69

0.65

1.4

1.7

—

(3042936) Bacteria identified in Isolate by Culture

1.61

0.62

3.3

2.8

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

118

1.55

0.61

2.8

—

(3023368) Bacteria identified in Blood by Culture

1.51

0.51

4.5

4.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.58

0.43

1.2

1.3

—

(3003396) Base excess in Arterial blood by calculation

1.53

0.42

2.0

28.0

-0.9

1.1

mmol/l

—

(3041096) Erythrocytes [Presence] in Urine by Automated

107

0.70

0.34

2.5

2.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

355

1.40

0.34

15.8

12.3

40.2

40.6

0.18

303

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.37

0.32

3.6

2.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

123

1.33

0.30

2.3

1.9

—

(3026782) Osmolality of Urine

1.28

0.29

2.1

2.2

610.0

589.3

mosm/kgh2o

—

(3000850) Epithelial cells [#/volume] in Urine

1.33

0.28

1.9

3.3

5.6

e6/l

—

(42870588) Differential panel, method unspecified - Blood

106

1.32

0.27

3.8

4.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.33

0.25

3.6

2.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.24

1.4

—

(3015736) pH of Urine

146

1.26

0.24

2.6

3.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.32

0.24

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

127

1.27

0.23

1.7

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

0.2

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.21

0.0

4.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

0.00

0.21

0.0

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

0.21

0.0

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.21

0.0

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

0.00

0.21

0.0

1.7

—

4.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

1.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.21

0.0

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

121

1.23

0.18

3.3

2.7

684.5

29.3

u/l

0.47

116

(3013512) EKG study

0.77

0.17

3.5

3.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1.14

0.16

2.6

3.2

1054.2

1001.2

ng/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

285

1.15

0.11

3.7

3.6

—

(3044889) 12 lead EKG panel

235

1.14

0.10

3.2

3.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.17

0.09

1.5

—

(40761511) CBC panel - Blood by Automated count

398

1.28

0.09

11.3

10.3

—

(3026008) Bacteria identified in Urine by Culture

0.84

0.07

3.5

2.4

—

(40768804) Tissue Pathology biopsy report

129

1.12

0.06

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

140

0.90

0.05

3.1

3.6

—

(3021589) Normoblasts [#/volume] in Blood

169

1.01

0.00

6.6

7.3

0.0

e9/l

0.50

139

(1761868) Lipid panel - Serum or Plasma

154

0.96

0.00

1.3

2.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1.03

0.00

2.1

2.2

261.7

136.1

u/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

4.3

—

2817.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

423.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.0

1.4

—

23.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

3.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.96

0.00

6.6

5.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

3.0

—

5.2

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.2

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

1.9

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

0.90

0.00

1.4

1.8

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.0

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

3.7

—

1.9

—

(1616796) Gas panel - Central venous blood

0.00

0.0

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

2.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

0.0

5.0

—

0.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.0

3.0

—

54.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

0.0

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.6

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.8

—

13.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.0

6.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.0

2.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

40.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.3

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.0

2.8

—

3.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

2.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

57.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

24.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_CRUSHI_INJURY_TRAUMAT_AMPUT_PART_ABDOMEN_LOWER_BACK_PELVIS – Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis (ST19_CRUSHI_INJURY_TRAUMAT_AMPUT_PART_ABDOMEN_LOWER_BACK_PELVIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints